The FDA's December 18th guidance on Data Integrity and Compliance with Drug CGMP
In stock
View at Merchant
This document outlines the FDA's requirements for data integrity controls in the pharmaceutical industry.
- The document details the FDA's requirements for data integrity controls, including record and metadata retention, audit trail reviews, backups, access controls, unique logins, and record storage locations.
Variants (1)
- Default Title — 0.00 USD — In stock
AI Readiness
Good foundation, but some important product data is still missing.
61%